Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph not_applicable
2
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

2

all time

Status Distribution
Other(2)

Detailed Status

unknown2

Development Timeline

Analytics

Development Status

Total Trials
2
Active
0
Success Rate
N/A
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

unknown2100%

Recent Activity

0 active trials
Showing 2 of 2
unknownnot_applicable

Whole-Body Diffusion-Weighted Magnetic Resonance Imaging (MRI) as a Response Biomarker for Metastatic Prostate Cancer

NCT05078151
unknownnot_applicable

Interest of Whole-body MRI Correlated to Spreading Sequences for Staging Neuroendocrine Tumors

NCT02786303

Clinical Trials (2)

Showing 2 of 2 trials
NCT05078151Not Applicable

Whole-Body Diffusion-Weighted Magnetic Resonance Imaging (MRI) as a Response Biomarker for Metastatic Prostate Cancer

Unknown
NCT02786303Not Applicable

Interest of Whole-body MRI Correlated to Spreading Sequences for Staging Neuroendocrine Tumors

Unknown

All 2 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
2